CSF1R and rheumatoid arthritis: Several safety studies of CSF1R inhibition in healthy subjects, patients with rheumatoid arthritis, and patients with advanced or metastatic cancers, including giant cell tumors, glioblastoma, and Hodgkin lymphoma, have been reported174,222–225.